PMC:7652766 / 93716-94155 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T132","span":{"begin":64,"end":73},"obj":"Phenotype"}],"attributes":[{"id":"A132","pred":"hp_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Antionori et al. (329), analyzing patients with severe COVID-19 pneumonia in an intensive care unit (ICU) who were treated for 10 days with RDV, found that on the 28th day, 38.9% showed improvement, 16.7% were still on mechanical ventilation, and 44.4% died. The data suggest that this treatment can benefit hospitalized patients who are not in the ICU, where the clinical result was better and adverse events are observed less frequently."}

{"project":"LitCovid-sentences","denotations":[{"id":"T458","span":{"begin":0,"end":258},"obj":"Sentence"},{"id":"T459","span":{"begin":259,"end":439},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Antionori et al. (329), analyzing patients with severe COVID-19 pneumonia in an intensive care unit (ICU) who were treated for 10 days with RDV, found that on the 28th day, 38.9% showed improvement, 16.7% were still on mechanical ventilation, and 44.4% died. The data suggest that this treatment can benefit hospitalized patients who are not in the ICU, where the clinical result was better and adverse events are observed less frequently."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3448","span":{"begin":34,"end":42},"obj":"Species"},{"id":"3449","span":{"begin":321,"end":329},"obj":"Species"},{"id":"3450","span":{"begin":140,"end":143},"obj":"Chemical"},{"id":"3451","span":{"begin":55,"end":73},"obj":"Disease"}],"attributes":[{"id":"A3448","pred":"tao:has_database_id","subj":"3448","obj":"Tax:9606"},{"id":"A3449","pred":"tao:has_database_id","subj":"3449","obj":"Tax:9606"},{"id":"A3450","pred":"tao:has_database_id","subj":"3450","obj":"MESH:C000606551"},{"id":"A3451","pred":"tao:has_database_id","subj":"3451","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Antionori et al. (329), analyzing patients with severe COVID-19 pneumonia in an intensive care unit (ICU) who were treated for 10 days with RDV, found that on the 28th day, 38.9% showed improvement, 16.7% were still on mechanical ventilation, and 44.4% died. The data suggest that this treatment can benefit hospitalized patients who are not in the ICU, where the clinical result was better and adverse events are observed less frequently."}